SCHEMBL1355684

SCHEMBL1355684

CC(C)c1ccc(C(=O)O)cc1C(=O)O

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACE2 Q9BYF1 3/20 0.67
KDM4E B2RXH2 1/20 0.52
GRM1 Q13255 2/20 0.47
MEN1 O00255 1/20 0.47
CYP1A2 P05177 1/20 0.47
KMT2A Q03164 1/20 0.47
TDP1 Q9NUW8 1/20 0.47
RXRA P19793 3/20 0.46
RXRB P28702 1/20 0.46
RXRG P48443 1/20 0.46
PTPN1 P18031 1/20 0.46
ALDH1A1 P00352 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
BCL2 P10415 1/20 0.45
MCL1 Q07820 1/20 0.45
GABRA1 P14867 1/20 0.44
GABRB1 P18505 1/20 0.44
CDC25A P30304 1/20 0.44
CDC25B P30305 1/20 0.44
HSD17B10 Q99714 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7009458 0.89 ACE2 (0.58) ACE2KDM4EGRM1MEN1CYP1A2
SCHEMBL6935737 0.88 ACE2 (0.57) ACE2KDM4EGRM1MEN1CYP1A2
SCHEMBL18309183 0.87 ACE2 (0.53) ACE2KDM4EMEN1KMT2ARXRA
SCHEMBL21104802 0.85 CDC25A (0.61) ACE2KDM4ETDP1RXRAALDH1A1
SCHEMBL27558455 0.85 ACE2 (0.54) ACE2KDM4EGRM1MEN1CYP1A2
SCHEMBL7109111 0.85 ACE2 (0.54) ACE2KDM4EGRM1MEN1CYP1A2
SCHEMBL1356407 0.84 ACE2 (0.67) ACE2KDM4EGRM1MEN1CYP1A2
SCHEMBL2159198 0.84 ACE2 (0.54) ACE2KDM4EGRM1RXRARXRB
SCHEMBL13816269 0.83 ACE2 (0.61) ACE2KDM4EGRM1MEN1CYP1A2
SCHEMBL8559784 0.83 PLA2G2D (0.54) ACE2KDM4EGRM1MEN1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230051807-A1 PORPHYRIN PHOTOSENSITIZER AND COBALOXIME COCATALYST AND METHODS OF USE THEREOF THE HONG KONG POLYTECHNIC UNIVERSITY (CN) 2023-02-16 US disclosed
EP-3230339-B1 EPOXY RESIN COMPOSITION, PREPREG, FIBER-REINFORCED PLASTIC MATERIAL, AND MANUFACTURING METHOD FOR FIBER-REINFORCED PLASTIC MATERIAL TORAY INDUSTRIES (JP) 2022-03-23 EP disclosed
US-10201803-B2 Polymer-metal organic framework materials and methods of using the same THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2019-02-12 US disclosed
US-20170362376-A1 EPOXY RESIN COMPOSITION, PREPREG, FIBER-REINFORCED PLASTIC MATERIAL, AND MANUFACTURING METHOD FOR FIBER-REINFORCED PLASTIC MATERIAL TORAY INDUSTRIES, INC. (JP) 2017-12-21 US disclosed
EP-3230339-A1 EPOXY RESIN COMPOSITION, PREPREG, FIBER-REINFORCED PLASTIC MATERIAL, AND MANUFACTURING METHOD FOR FIBER-REINFORCED PLASTIC MATERIAL Toray Industries, Inc. (JP) 2017-10-18 EP disclosed
CN-105435852-B The preparation method of mesoporous composite material and catalyst and its preparation method and application and the dioxolanes of 2,2 dimethyl, 4 methyl 1,3 中国石油化工股份有限公司 2017-10-03 CN disclosed
CN-105435851-B The preparation method of mesoporous composite material and catalyst and its preparation method and application and the dioxolanes of 2,2 dimethyl, 4 methyl 1,3 中国石油化工股份有限公司 2017-09-29 CN disclosed
CN-105214735-B The preparation method of mesoporous composite material and catalyst and its preparation method and application and the dioxolanes of 2,2 dimethyl, 4 methyl 1,3 中国石油化工股份有限公司 2017-06-30 CN disclosed
CN-106902872-A A kind of isocyanate polymeric catalyst and preparation method thereof, and its method for preparing PIC 万华化学集团股份有限公司 2017-06-30 CN disclosed
WO-2016087935-A1 EPOXY RESIN COMPOSITION, PREPREG, FIBER-REINFORCED PLASTIC MATERIAL, AND MANUFACTURING METHOD FOR FIBER-REINFORCED PLASTIC MATERIAL TORAY INDUSTRIES, INC. (JP) 2016-06-09 WO disclosed
US-20080227946-A1 Thermosetting Composition and Curing Method Thereof SHOWA DENKO K.K. 2008-09-18 US disclosed
US-20070161685-A1 HETEROCYCLIC CETP INHIBITORS BRISTOL-MYERS SQUIBB COMPANY 2007-07-12 US disclosed
US-20070135631-A1 HETEROCYCLIC CETP INHIBITORS BRISTOL-MYERS SQUIBB COMPANY 2007-06-14 US disclosed
EP-1732980-A1 THERMOSETTING COMPOSITION AND CURING METHOD THEREOF SHOWA DENKO KABUSHIKI KAISHA (JP) 2006-12-20 EP disclosed
US-20060257727-A1 Reactive polymer-supporting porous film for battery seperator and use thereof NITTO DENKO CORPORATION (JP) 2006-11-16 US disclosed
EP-1667253-A1 REACTIVE POLYMER-SUPPORTING POROUS FILM FOR BATTERY SEPARATOR AND USE THEREOF NITTO DENKO CORPORATION (JP) 2006-06-07 EP disclosed
WO-2005097882-A1 THERMOSETTING COMPOSITION AND CURING METHOD THEREOF SHOWA DENKO K.K. (JP) 2005-10-20 WO disclosed
US-6906116-B2 Unsaturated polyester compounds, resins curable with actinic energy ray, processes for the production thereof, and curable compositions KANAGAWA UNIVERSITY (JP) 2005-06-14 US disclosed
US-20050064336-A1 Unsaturated group-containing multi-branched compounds, curable compositions containing the same, and cured products thereof TAIYO INK MANUFACTURING CO., LTD. (JP) 2005-03-24 US disclosed
US-20040039087-A1 Unsaturated polyester compounds, resins curable with actinic energy ray, processes for the production thereof, and curable compositions KANAGAWA UNIVERSITY (JP) 2004-02-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070161685-A1 HETEROCYCLIC CETP INHIBITORS CETP, CES1, NPC1 ACE2 1301/4885KDM4E 1618/4885GRM1 4826/4885
US-20230051807-A1 PORPHYRIN PHOTOSENSITIZER AND COBALOXIME COCATALYST AND METHODS OF USE THEREOF PPOX, HMBS, PNPO ACE2 4418/4885KDM4E 2348/4885GRM1 2946/4885
US-20070135631-A1 HETEROCYCLIC CETP INHIBITORS CETP, CES1, NPC1 ACE2 1301/4885KDM4E 1618/4885GRM1 4826/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.